Grantham, Mayo, Van Otterloo & Co (GMO)’s Illumina ILMN Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-179,439	Closed	-$24.3M	–	531
2023 Q4	$24.3M	Buy	+179,439	New	+$20.7M	0.11%	145
2022 Q4	–	Sell	-1,645	Closed	-$305K	–	742
2022 Q3	$305K	Buy	1,645 +206	+14%	+$40.8K	﹤0.01%	627
2022 Q2	$258K	Buy	+1,439	New	+$367K	﹤0.01%	685
2019 Q2	–	Sell	-2,159	Closed	-$652K	–	736
2019 Q1	$652K	Buy	2,159 +103	+5%	+$30K	﹤0.01%	544
2018 Q4	$600K	Buy	+2,056	New	+$637K	﹤0.01%	411

Other funds holding ILMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ILMN Position: Q1 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Illumina (ILMN) in Q1 2024, closing a stake of 179,439 shares — an estimated $24.3M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ILMN in Q4 2018 and held it in 5 quarters. The position peaked at $24.3M in Q4 2023. 794 funds tracked by Wall St. Rank hold ILMN as of Q1 2024.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Illumina position as of Q1 2024 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 179,439 Illumina shares in Q1 2024, an estimated $24.3M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Illumina in Q4 2018 and held it in 5 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Illumina position peaked at $24.3M in Q4 2023.
794 funds tracked by Wall St. Rank held Illumina as of Q1 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2024, filed 14 May 2024.